Show Summary Details
Page of

Risk-adapted management of BPH 

Risk-adapted management of BPH
Risk-adapted management of BPH

Ingrid Berger

and Stephan Madersbacher

Page of

PRINTED FROM OXFORD MEDICINE ONLINE ( © Oxford University Press, 2021. All Rights Reserved. Under the terms of the licence agreement, an individual user may print out a PDF of a single chapter of a title in Oxford Medicine Online for personal use (for details see Privacy Policy and Legal Notice).

date: 26 July 2021

Senior Adults

Age, co-morbidity, urodynamic considerations and treatment related complications need to be considered

All drugs currently licensed seem to be safe and effective in the elderly; minimal invasive procedures are an alternative to TURP in patients with high-anaesthesiologic risks.

Patients at risk of progression

BPH/BPE/BPO are progressive disorders

prostate volume is the strongest predictor for the risk of acute urinary retention and the need for surgery

Plant extracts and α‎-blockers have––in contrast to 5 -reductase inhibitors––no relevant impact on the natural history of the disease

A risk-stratified management as elaborated herein seems to be advisable.

Access to the complete content on Oxford Medicine Online requires a subscription or purchase. Public users are able to search the site and view the abstracts for each book and chapter without a subscription.

Please subscribe or login to access full text content.

If you have purchased a print title that contains an access token, please see the token for information about how to register your code.

For questions on access or troubleshooting, please check our FAQs, and if you can't find the answer there, please contact us.